Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Thyroid Hormones in Prematures

NCT02103998 is registered in ClinicalTrials.gov with New York Medical College as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02103998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Thyroid Hormones in Prematures
Lead sponsor
New York Medical College
Phase
Phase 3
Overall status
Withdrawn
Start date
July 1, 2020
Completion date
May 31, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transient hypothyroxinemia of prematurity (thop)